What impact is COVID-19 having on pharmaceutical supply chains? In this podcast, we feature an article that reports on the concerns raised by industry groups, including reduced availability of international air transportation and increasing costs for shipping medicines into the US. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers)
- Industry groups weigh in on supply-chain concerns
- International air transportation availability and costs
- Repatriation of pharmaceutical manufacturing back to the US
- Potential supply disruptions of drugs identified as potential treatments against COVID-19
- Prescription refills